PSL Group Executive and Leadership Team

Michele Fearon, the Chief Executive Officer at PSL Group, directs the overarching corporate strategy and global vision for the organization. Fearon manages the alignment of pharmaceutical market research services with the evolving needs of healthcare communication agencies across North America, Europe, and Asia. By overseeing the integration of clinical evidence into professional marketing messages, the Chief Executive Officer ensures that all programs resonate effectively with physicians. Michele Fearon maintains constant communication with the Board to drive long-term growth and operational excellence. This leadership role involves navigating complex international regulatory environments to maintain the company's competitive edge in the healthcare sector. Through the implementation of rigorous quality standards, Fearon secures the firm's reputation as a premier provider of online fieldwork services. Ultimately, the Chief Executive Officer fosters a culture of innovation that supports the delivery of high-value PV update programs and educational content for global clients.

Neil Corner, the Chief Executive Officer, AI LaunchPad, PSL Group at PSL Group, architects the technological transformation of market research through advanced artificial intelligence. Corner drives the development of automated tools that streamline the delivery of PV update programs and clinical evidence reviews. By overseeing the AI LaunchPad division, the Chief Executive Officer, AI LaunchPad, PSL Group ensures that machine learning capabilities enhance the precision of physician engagement strategies. Neil Corner collaborates with internal data science teams to refine predictive models that identify emerging healthcare trends across international markets. This leadership role involves scaling AI-driven solutions to meet the specific demands of pharmaceutical consulting agencies. Through the deployment of sophisticated algorithms, Corner optimizes the efficiency of online fieldwork services. Ultimately, the Chief Executive Officer, AI LaunchPad, PSL Group accelerates the digital evolution of the company, ensuring that technological advancements remain at the core of all client-facing healthcare communication initiatives.

Tim Houghton, the Chief Executive Officer, MEC Domain at PSL Group, directs the strategic expansion of medical education and clinical communication programs. Houghton manages the MEC Domain to ensure that professional marketing messages effectively bridge the gap between clinical evidence and physician practice. By overseeing the creation of on-label education content, the Chief Executive Officer, MEC Domain ensures that all materials meet the highest standards of accuracy and relevance for healthcare agencies. Tim Houghton coordinates with global teams to tailor educational initiatives for diverse regional markets, including Latin America and Europe. This leadership role involves maintaining strong relationships with key opinion leaders to validate the clinical integrity of all programs. Through the continuous refinement of educational methodologies, Houghton drives higher engagement rates among medical professionals. Ultimately, the Chief Executive Officer, MEC Domain strengthens the company's market position by delivering evidence-based solutions that support informed decision-making in the pharmaceutical industry.

Jim Karr, the Chief Financial Officer at PSL Group, directs the financial health and fiscal planning of the organization. Karr manages the allocation of capital to support the expansion of online fieldwork services and global operations. By overseeing the budgeting process, the Chief Financial Officer ensures that resources remain aligned with the company's strategic goals in North America and international markets. Jim Karr monitors revenue streams from pharmaceutical market research and healthcare communication contracts to maintain long-term profitability. This leadership role involves providing the Board with detailed financial analysis to guide investment decisions in new technology and service lines. Through the implementation of robust financial controls, Karr mitigates operational risks and ensures compliance with international accounting standards. Ultimately, the Chief Financial Officer supports the company's growth trajectory by maintaining a stable financial foundation that allows for continuous investment in high-impact medical education and research programs.

Elizabeth Barron, the Chief Operating Officer at PSL Group, directs the daily execution of online fieldwork services and internal business processes. Barron manages the operational infrastructure that supports pharmaceutical market research and healthcare communication agencies across multiple continents. By overseeing the coordination between regional offices, the Chief Operating Officer ensures that project delivery remains consistent and efficient. Elizabeth Barron implements standardized workflows to optimize the production of PV update programs and clinical evidence reviews. This leadership role involves streamlining cross-functional collaboration to improve service delivery speed and quality. Through the management of global operational resources, Barron drives the scalability of the company's service offerings. Ultimately, the Chief Operating Officer maintains the operational agility required to respond to the fast-paced needs of the pharmaceutical industry, ensuring that all client engagements are executed with precision and adherence to strict industry timelines.

Stephanie Kennedy-Harris, the Group President at PSL Group, directs the performance and growth of key business units within the organization. Kennedy-Harris manages the strategic direction of service delivery to ensure that pharmaceutical market research and healthcare communication agencies receive high-value insights. By overseeing the alignment of professional marketing messages with clinical evidence, the Group President ensures that all programs meet the specific needs of international clients. Stephanie Kennedy-Harris coordinates with regional leaders to drive market penetration in North America and Europe. This leadership role involves fostering strong client relationships to secure long-term partnerships and recurring revenue. Through the implementation of best practices across business units, Kennedy-Harris improves the overall quality of service delivery. Ultimately, the Group President supports the company's mission by ensuring that all operational activities contribute to the successful dissemination of medical information and the improvement of physician engagement.

Kristin Stockett, the Executive President, Enterprise Partnerships, Peerdirect at PSL Group, directs the expansion of large-scale client relationships through the Peerdirect platform. Stockett manages the strategic partnerships that connect pharmaceutical companies with professional market research and healthcare communication agencies. By overseeing the enterprise sales strategy, the Executive President, Enterprise Partnerships, Peerdirect ensures that the company's services reach a broad network of global stakeholders. Kristin Stockett collaborates with internal teams to tailor partnership models that address the unique challenges of international healthcare markets. This leadership role involves identifying new opportunities for collaboration that leverage the company's clinical evidence and marketing expertise. Through the development of long-term enterprise agreements, Stockett drives consistent revenue growth. Ultimately, the Executive President, Enterprise Partnerships, Peerdirect strengthens the company's market position by building a robust ecosystem of partners dedicated to improving physician education and clinical outcomes.

Kim Nachbaur, the Executive President, Enterprise Partnerships at PSL Group, directs the cultivation of strategic alliances with major healthcare communication and consulting agencies. Nachbaur manages the enterprise partnership portfolio to ensure that the company's online fieldwork services remain the preferred choice for global pharmaceutical clients. By overseeing the negotiation and management of high-value contracts, the Executive President, Enterprise Partnerships ensures that the firm maintains a strong presence in key international markets. Kim Nachbaur works closely with other executive leaders to align partnership goals with the company's overall mission of delivering clinical evidence and professional marketing programs. This leadership role involves identifying market trends that necessitate new collaborative models. Through the proactive management of client expectations, Nachbaur drives high levels of satisfaction and retention. Ultimately, the Executive President, Enterprise Partnerships expands the company's reach by building sustainable relationships that support the delivery of critical medical education and research services.

Jill Myerow, the Group President, Business Unit, Peerscience at PSL Group, directs the specialized operations of the Peerscience division. Myerow manages the integration of scientific rigor into the company's market research and healthcare communication programs. By overseeing the development of evidence-based content, the Group President, Business Unit, Peerscience ensures that all marketing messages are grounded in clinical data. Jill Myerow coordinates with research teams to deliver high-quality PV update programs that resonate with physicians across international markets. This leadership role involves maintaining the scientific integrity of all client deliverables while meeting strict project timelines. Through the management of specialized talent, Myerow drives innovation in how clinical evidence is presented to healthcare professionals. Ultimately, the Group President, Business Unit, Peerscience supports the company's commitment to excellence by ensuring that all scientific communications are accurate, impactful, and aligned with the latest medical advancements.

Ahsan Haque, the Chief Technology Officer at PSL Group, directs the technical architecture and digital security of the company's platforms. Haque manages the development of secure systems that facilitate online fieldwork services for pharmaceutical and healthcare clients. By overseeing the IT infrastructure, the Chief Technology Officer ensures that all data handling processes comply with international privacy regulations. Ahsan Haque leads the integration of new software solutions that enhance the delivery of clinical evidence and marketing programs. This leadership role involves collaborating with other C-suite executives to align technical capabilities with the company's broader strategic objectives. Through the continuous monitoring of system performance, Haque maintains high availability for global users. Ultimately, the Chief Technology Officer drives the digital transformation of the firm, ensuring that the technological backbone remains robust, scalable, and capable of supporting the complex data requirements of modern pharmaceutical market research.